Literature DB >> 18651653

Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene: an animal model for therapeutic studies.

Monique A Lorson1, Lee D Spate, Randall S Prather, Christian L Lorson.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive disorder that is characterized by the degeneration of the motor neurons of the spinal cord leading to muscle atrophy. SMA is a result of a loss-of-function of the gene survival motor neuron-1 (SMN1). We have chosen to generate a transgenic swine model of SMA for the development and testing of therapeutics and evaluation of toxicology. To this end, we report the first cloning and identification of the swine SMN1 gene and show that there is significant sequence homology between swine and human SMN throughout the coding region. Reverse transcriptase-polymerase chain reaction results demonstrated slight changes in SMN RNA expression during development and in different tissues. In contrast, protein expression profiles were dramatically different based upon different tissues and developmental stages, consistent with human SMN expression. Porcine SMN localization is consistent with human SMN, localizing diffusely within the cytoplasm and in punctate nuclear structures characteristic of nuclear gems. Importantly, transient transfection of porcine SMN1 in 3813 SMA type 1 fibroblasts demonstrate that porcine SMN1 can rescue the deficiency of SMN protein and gem formation in these cells. These studies provide the first characterization of the porcine SMN1 gene and SMN protein and suggest that a transgenic swine SMA model is feasible. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651653      PMCID: PMC2556073          DOI: 10.1002/dvdy.21642

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  57 in total

1.  An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.

Authors:  C L Lorson; E J Androphy
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

2.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

Authors:  U R Monani; M Sendtner; D D Coovert; D W Parsons; C Andreassi; T T Le; S Jablonka; B Schrank; W Rossoll; W Rossol; T W Prior; G E Morris; A H Burghes
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

3.  Refined physical map of the spinal muscular atrophy gene (SMA) region at 5q13 based on YAC and cosmid contiguous arrays.

Authors:  N Roy; M D McLean; A Besner-Johnston; C Lefebvre; M Salih; J D Carpten; A H Burghes; Z Yaraghi; J E Ikeda; R G Korneluk
Journal:  Genomics       Date:  1995-04-10       Impact factor: 5.736

Review 4.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).

Authors:  B Wirth
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems.

Authors:  T Giesemann; S Rathke-Hartlieb; M Rothkegel; J W Bartsch; S Buchmeier; B M Jockusch; H Jockusch
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

6.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

7.  The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy.

Authors:  P Burlet; C Huber; S Bertrandy; M A Ludosky; I Zwaenepoel; O Clermont; J Roume; A L Delezoide; J Cartaud; A Munnich; S Lefebvre
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

8.  Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli.

Authors:  B Charroux; L Pellizzoni; R A Perkinson; J Yong; A Shevchenko; M Mann; G Dreyfuss
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

9.  Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems.

Authors:  B Charroux; L Pellizzoni; R A Perkinson; A Shevchenko; M Mann; G Dreyfuss
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

10.  Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients.

Authors:  M Gennarelli; M Lucarelli; F Capon; A Pizzuti; L Merlini; C Angelini; G Novelli; B Dallapiccola
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

View more
  7 in total

Review 1.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

Review 2.  Antisense oligonucleotides for the treatment of spinal muscular atrophy.

Authors:  Paul N Porensky; Arthur H M Burghes
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

3.  Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA.

Authors:  Monique A Lorson; Lee D Spate; Melissa S Samuel; Clifton N Murphy; Christian L Lorson; Randall S Prather; Kevin D Wells
Journal:  Transgenic Res       Date:  2011-02-25       Impact factor: 2.788

Review 4.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

5.  Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analyses.

Authors:  Dione T Kobayashi; Rory J Olson; Laurel Sly; Chad J Swanson; Brett Chung; Nikolai Naryshkin; Jana Narasimhan; Anuradha Bhattacharyya; Michael Mullenix; Karen S Chen
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

6.  Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit.

Authors:  Meaghan Van Alstyne; Ivan Tattoli; Nicolas Delestrée; Yocelyn Recinos; Eileen Workman; Lamya S Shihabuddin; Chaolin Zhang; George Z Mentis; Livio Pellizzoni
Journal:  Nat Neurosci       Date:  2021-04-01       Impact factor: 24.884

7.  Absence of an intron splicing silencer in porcine Smn1 intron 7 confers immunity to the exon skipping mutation in human SMN2.

Authors:  Thomas Koed Doktor; Lisbeth Dahl Schrøder; Henriette Skovgaard Andersen; Sabrina Brøner; Anna Kitewska; Charlotte Brandt Sørensen; Brage Storstein Andresen
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.